Detalhe da pesquisa
1.
Aspartate ß-hydroxylase modulates cellular senescence through glycogen synthase kinase 3ß in hepatocellular carcinoma.
Hepatology
; 63(4): 1213-26, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683595
2.
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab.
JAMA Oncol
; 9(1): 102-111, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480191
3.
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study.
Oncotarget
; 13: 257-270, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35111281
4.
Tumor mutational burden in lung cancer: a systematic literature review.
Oncotarget
; 10(61): 6604-6622, 2019 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762941
5.
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study.
Oncotarget
; 13: 1306, 2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473137
6.
Anti-Tumor Effects of Second Generation ß-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
PLoS One
; 11(3): e0150336, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26954680
7.
Aspartate-ß-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas.
Heliyon
; 2(12): e00203, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27981247